TOSI, GIAN MARCO
 Distribuzione geografica
Continente #
NA - Nord America 14.722
EU - Europa 12.829
AS - Asia 7.147
SA - Sud America 1.337
AF - Africa 433
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 13
AN - Antartide 1
Totale 36.510
Nazione #
US - Stati Uniti d'America 14.510
GB - Regno Unito 2.848
RU - Federazione Russa 2.673
IT - Italia 2.345
CN - Cina 2.255
SG - Singapore 2.213
IE - Irlanda 1.388
BR - Brasile 1.081
VN - Vietnam 857
SE - Svezia 733
FR - Francia 675
DE - Germania 662
UA - Ucraina 633
HK - Hong Kong 557
KR - Corea 372
FI - Finlandia 300
IN - India 233
ZA - Sudafrica 192
TR - Turchia 146
CA - Canada 106
NL - Olanda 100
ES - Italia 89
BD - Bangladesh 87
AR - Argentina 71
IQ - Iraq 67
MX - Messico 65
BE - Belgio 63
PK - Pakistan 57
JP - Giappone 54
NG - Nigeria 54
PL - Polonia 52
CH - Svizzera 51
CI - Costa d'Avorio 46
AT - Austria 39
VE - Venezuela 38
EC - Ecuador 37
KE - Kenya 36
CZ - Repubblica Ceca 35
ID - Indonesia 32
CO - Colombia 29
LT - Lituania 29
AU - Australia 27
CL - Cile 27
SA - Arabia Saudita 27
UZ - Uzbekistan 22
AE - Emirati Arabi Uniti 21
BY - Bielorussia 21
EG - Egitto 21
MA - Marocco 21
DZ - Algeria 18
IR - Iran 18
JO - Giordania 18
PY - Paraguay 15
BO - Bolivia 14
LV - Lettonia 13
PH - Filippine 13
TN - Tunisia 13
NP - Nepal 12
PE - Perù 12
KZ - Kazakistan 11
LB - Libano 11
RO - Romania 10
RS - Serbia 10
UY - Uruguay 10
MY - Malesia 9
PT - Portogallo 9
AL - Albania 8
IL - Israele 8
PS - Palestinian Territory 8
EU - Europa 7
GR - Grecia 7
JM - Giamaica 7
PA - Panama 7
AZ - Azerbaigian 6
CR - Costa Rica 6
EE - Estonia 6
HN - Honduras 5
HU - Ungheria 5
LY - Libia 5
MK - Macedonia 5
SN - Senegal 5
TT - Trinidad e Tobago 5
BH - Bahrain 4
DK - Danimarca 4
ET - Etiopia 4
LU - Lussemburgo 4
NO - Norvegia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
AO - Angola 3
CG - Congo 3
CY - Cipro 3
GE - Georgia 3
GY - Guiana 3
LA - Repubblica Popolare Democratica del Laos 3
NI - Nicaragua 3
SY - Repubblica araba siriana 3
TG - Togo 3
BA - Bosnia-Erzegovina 2
CW - ???statistics.table.value.countryCode.CW??? 2
Totale 36.470
Città #
Southend 2.524
Dallas 2.080
Fairfield 1.398
Dublin 1.373
Singapore 1.222
Ashburn 1.088
Moscow 761
Santa Clara 716
Chandler 674
Woodbridge 664
Beijing 535
Houston 534
Seattle 533
Hong Kong 522
Jacksonville 506
Wilmington 496
San Jose 484
Hefei 482
Menlo Park 478
Siena 468
Cambridge 451
Ann Arbor 416
New York 375
Seoul 347
Milan 261
Princeton 258
Los Angeles 250
The Dalles 244
Ho Chi Minh City 227
Hanoi 206
Lauterbourg 194
Munich 180
Johannesburg 176
Nanjing 157
Council Bluffs 145
Helsinki 139
Dong Ket 134
Rome 125
Florence 110
São Paulo 102
San Mateo 100
Dearborn 98
Boardman 94
San Diego 90
Izmir 83
Orem 79
Buffalo 77
Nanchang 69
Shanghai 67
Chicago 58
London 58
Bengaluru 57
Redondo Beach 57
Frankfurt am Main 55
Turku 55
Málaga 54
Brussels 52
Columbus 52
Abuja 51
Abidjan 46
Guangzhou 46
Warsaw 46
Rio de Janeiro 44
Hebei 42
Tokyo 41
Brooklyn 40
Shenyang 40
Chennai 39
Changsha 37
Da Nang 36
Kunming 35
Düsseldorf 34
Nuremberg 34
Redwood City 34
Jinan 33
Montreal 33
San Francisco 33
Stockholm 32
Toronto 32
Washington 32
Tianjin 31
Lappeenranta 28
Atlanta 26
Phoenix 26
Portsmouth 26
Turin 25
Venezia 25
Belo Horizonte 24
Haiphong 24
Denver 23
Lahore 22
Mexico City 22
Fremont 21
Mumbai 21
Tashkent 21
Boston 20
Jiaxing 20
Palermo 20
Poplar 20
Baghdad 19
Totale 24.594
Nome #
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases 862
CD93 as a potential target in neovascular Age-related Macular Degeneration 396
TGF-β concentrations and activity are down-regulated in the aqueous humor of patients with neovascular age-related macular degeneration 389
Dissecting the CD93-Multimerin 2 interaction involved in cell adhesion and migration of the activated endothelium 355
Corneal complications during and after vitrectomy for retinal detachment in photorefractive keratectomy treated eyes 352
Bifocal refractive corneal inlay implantation to improve near vision in emmetropic presbyopic patients 352
Forty-two-month outcome of intravitreal bevacizumab in myopic choroidal neovascularization 344
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 342
Complex retinal detachment in phakic patients: previtrectomy. Phacoemulsification Versus Combined Phacovitrectomy 341
HTRA1 and TGF-β1 concentrations in the aqueous humor of patients with neovascular age-related macular degeneration 332
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 326
MicroRNA expression in the aqueous humor of patients with diabetic macular edema 323
A case of conjunctival involvement with mycosis fungoides successfully treated by surgery. 320
An In Vivo Confocal Microscopy Analysis of Effects of Topical Antiglaucoma Therapy With Preservative on Corneal Innervation and Morphology. 319
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 312
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 311
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 308
Corneal Subbasal Nerve Density and Sensitivity After Pars Plana Vitrectomy Using Contact or Noncontact Wide-Angle Viewing Systems 307
Long-term evaluation of corneal sub-basal nerve recovery after photorefractive keratectomy and influence of pars plana vitrectomy 304
The small GTPase Rab5c is a key regulator of trafficking of the CD93/Multimerin-2/β1 integrin complex in endothelial cell adhesion and migration 294
Superior properties of N-acetylcysteine ethyl ester over n-acetyl cysteine to prevent retinal pigment epithelial cells oxidative damage 291
Mini-incision cataract surgery and toric lens implantation for the reduction of high myopic astigmatism in patients with pellucid marginal degeneration 289
Vitreous incarceration in sclerotomies after valved 23-, 25-, or 27-gauge and nonvalved 23- or 25-gauge macular surgery 283
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 283
Co-Expression of Podoplanin and CD44 in Proliferative Vitreoretinopathy Epiretinal Membranes 282
Amniotic membrane graft: histopathological findings in five cases. 280
A randomized prospective study comparing trabeculectomy with and without the use of a new removable suture 279
Response to the letter to the editor entitled "Forty-two-month outcome of intravitreal bevacizumab in myopic choroidal neovascularization" 278
CD-34 stromal expression pattern in normal and altered human corneas 277
Amniotic membrane transplantation in ocular surface disorders. 277
The extracellular matrix complexity of idiopathic epiretinal membranes and the bilaminar arrangement of the associated internal limiting membrane in the posterior retina 277
Capsule contraction syndrome with a microincision foldable hydrophilic acrylic intraocular lens: two case reports and review of the literature 275
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 270
F6H8 as an Intraoperative Tool and F6H8/Silicone Oil as a Postoperative Tamponade in Inferior Retinal Detachment with Inferior PVR 265
The peculiar pattern of type IV collagen deposition in epiretinal membranes 265
Behçet’s syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 261
A preliminary report on the characterization of epiretinal membranes excised from patients affected by macular pucker 260
The Binding of CD93 to Multimerin-2 Promotes Choroidal Neovascularization 260
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 258
The Incidence of Rhegmatogenous Retinal Complications in Macular Surgery after Prophylactic Preoperative Laser Retinopexy 256
Phacoemulsificator and sterile drapes contamination during cataract surgery: a microbiological study 252
Impact of intraoperative topical hydroxypropyl methylcellulose 2% versus sodium hyaluronate 1.2% on corneal reepithelialization after intentional epithelial debridement during vitrectomy 252
A study of quiet eye's phenomenon in the shooting section of "laser run" of modern pentathlon 247
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 244
Cd93 signaling via rho proteins drives cytoskeletal remodeling in spreading endothelial cells 244
Heat shock protein (HSP)90 involvement in the development of idiopathic epiretinal membranes 243
Disease pathways in proliferative vitreoretinopathy: an ongoing challenge 241
Vitreous incarceration in sutured vs non-sutured sclerotomies after 25-gauge macular surgery 240
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 238
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 237
Untangling the extracellular matrix of idiopathic epiretinal membrane: a path winding among structure, interactomics and translational medicine 237
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 236
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 233
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 233
Contrast sensitivity evaluation of aspheric and spherical intraocular lenses 2 years after implantation. 232
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 230
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 230
Corneal collagen cross-linking to stop corneal ectasia exacerbated by radial keratotomy 228
Prophylactic preoperative laser retinopexy does not reduce the occurrence of rhegmatogenous retinal complications in macular surgery 225
The eye involvement in monogenic autoinflammatory diseases: Literature review and update 224
The Controversial Role of TGF-β in Neovascular Age-Related Macular Degeneration Pathogenesis. 224
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 222
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry 220
Clinical and ultrasound biomicroscopic features in iris melanocytoma. 220
Flap displacement during vitrectomy 24 months after laser in situ keratomileusis 219
Unilateral retinitis pigmentosa in a woman and pigmented paravenous chorioretinal atrophy in her daughter and son 218
A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project 216
In vivo confocal microscopy and anterior segment optical coherence tomography in a case of alternaria keratitis 216
In vivo confocal microscopy in recurrent granular dystrophy in corneal graft after penetrating keratoplasty 216
Treatment of macular edema because of occlusive vasculitis with bevacizumab (avastin): efficacy of three consecutive monthly injections 215
Diagnosis and management of traumatic cyclodialysis cleft 215
Closed-system and open-sky capsulorhexis for combined cataract extraction and corneal transplantation. 213
The C-type lectin CD93 controls endothelial cell migration via activation of the Rho family of small GTPases 213
Molecular modulators of anti-VEGF response in neovascular age-related macular degeneration: aqueous humor dynamics of CD93 and endocannabinoids 208
Comparison of AcrySof MA30BA and Sensar AR40 acrylic intraocular lenses 207
IL-6 blockade in the management of non-infectious uveitis 206
Glare disability and spherical aberration with five foldable intraocular lenses: a prospective randomized study 204
Corneal invasion of ocular surface squamous neoplasia after clear corneal phacoemulsification: in vivo confocal microscopy analysis 204
Usher syndrome type 1 associated with primary ciliary aplasia 202
Translationally Controlled Tumour Protein (TCTP) is present in human cornea and increases in herpetic keratitis 202
Genetic and epigenetic alterations of RB2/p130 tumor suppressor gene in human sporadic retinoblastoma: implication for pathogenesis and therapeutic approach 201
Expression of RB2/p130 tumor-suppressor gene in AIDS-related non-Hodgkin's lymphomas: implications for disease pathogenesis 201
Dimerization of the C-type lectin-like receptor CD93 promotes its binding to Multimerin-2 in endothelial cells 200
Cell composition and immunohistochemical detection of VEGF, TGF-ß and TNF-α in proliferative vitreoretinopathy 199
Digital surface microscopy analysis of conjunctival pigmented lesions: a preliminary study. 198
Iontophoresis corneal cross-linking with enhanced fluence and pulsed UV-A light: 3-year clinical results 198
In vivo confocal microscopy in bilateral herpetic keratitis: a case report 197
New molecular targets for the treatment of neovascular age-related macular degeneration 197
In vivo confocal microscopy: qualitative investigation of the conjunctival and corneal surface in open angle glaucomatous patients undergoing the XEN-Gel implant, trabeculectomy or medical therapy 196
Development and implementation of the AIDA international registry for patients with non-infectious uveitis 195
Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience 192
Development and implementation of the AIDA International Registry for patients with Behçet's disease 190
Visual field loss progression after macular hole surgery. 190
Management of severe hypotony with intravitreal injection of viscoelastic. 189
The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases 189
LRG1 expression is elevated in the eyes of patients with neovascular age-related macular degeneration 188
Ocular involvement in generalized fixed drug eruption from nimesulide 187
Cytoplasmic and nuclear interaction between Rb family proteins and PAI-2: a physiological cross-talk in human corneal and conjunctival epithelial cells 187
Optical aberrations in pseudophakic eyes after 2.5-mm Nd:YAG laser capsulotomy for posterior capsule opacification 187
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study 185
Totale 25.527
Categoria #
all - tutte 105.632
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.632


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021864 0 0 0 0 0 0 0 0 0 294 267 303
2021/20222.353 220 317 182 192 121 55 121 95 122 233 252 443
2022/20232.670 169 236 346 347 231 526 73 206 276 87 92 81
2023/20242.605 82 70 214 132 128 778 773 71 24 78 74 181
2024/20256.039 244 274 506 328 799 397 253 410 517 300 611 1.400
2025/202612.588 996 2.110 1.636 1.678 2.479 514 1.557 447 507 664 0 0
Totale 37.117